Breaking News Instant updates and real-time market news.

SMUUY

Siam Commercial Bank

$0.00 /

+ (+0.00%)

11:16
07/02/20
07/02
11:16
07/02/20
11:16

Siam Commercial Bank resumed with a Neutral at Goldman Sachs

Goldman Sachs analyst Melissa Kuang resumed coverage of Siam Commercial Bank with a Neutral rating and THB 85.80 price target.

SMUUY Siam Commercial Bank
$0.00 /

+ (+0.00%)

02/25/20 Credit Suisse
Siam Commercial Bank upgraded to Neutral from Underperform at Credit Suisse
01/20/20 JPMorgan
Siam Commercial Bank downgraded to Underweight from Neutral at JPMorgan
01/20/20 Credit Suisse
Siam Commercial downgraded to Underperform from Outperform at Credit Suisse
01/20/20 Macquarie
Siam Commercial Bank downgraded to Underperform from Neutral at Macquarie

TODAY'S FREE FLY STORIES

Hot Stocks
Medipharm Labs to supply cannabis oil to XLR8 Brazil » 07:09
09/22/20
09/22
07:09
09/22/20
07:09
MEDIF

Medipharm Labs

$0.00 /

+ (+0.00%)

MediPharm Labs announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MEDIF Medipharm Labs
$0.00 /

+ (+0.00%)

MEDIF Medipharm Labs
$0.00 /

+ (+0.00%)

MEDIF Medipharm Labs
$0.00 /

+ (+0.00%)

Recommendations
Nike price target raised to $115 but limited upside seen, says Baird » 07:09
09/22/20
09/22
07:09
09/22/20
07:09
NKE

Nike

$113.31 /

-1.32 (-1.15%)

Baird analyst Jonathan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NKE Nike
$113.31 /

-1.32 (-1.15%)

NKE Nike
$113.31 /

-1.32 (-1.15%)

09/18/20 Needham
Nike price target raised to $132 from $113 at Needham
09/18/20 Morgan Stanley
Nike price target raised to $142 from $121 at Morgan Stanley
09/18/20 Raymond James
Nike price target raised to $121 from $115 at Raymond James
09/18/20 Barclays
Nike price target raised to $132 from $118 at Barclays
NKE Nike
$113.31 /

-1.32 (-1.15%)

NKE Nike
$113.31 /

-1.32 (-1.15%)

NKE Nike
$113.31 /

-1.32 (-1.15%)

NKE Nike
$113.31 /

-1.32 (-1.15%)

Hot Stocks
Lowe's to install pickup lockers at all U.S. stores by end of March, 2021 » 07:09
09/22/20
09/22
07:09
09/22/20
07:09
LOW

Lowe's

$159.61 /

-0.52 (-0.32%)

To continue to improve…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LOW Lowe's
$159.61 /

-0.52 (-0.32%)

LOW Lowe's
$159.61 /

-0.52 (-0.32%)

09/18/20
Fly Intel: Top five analyst downgrades
09/18/20 Oppenheimer
Oppenheimer downgrades Home Depot, Lowe's on near-term risks
09/18/20 Oppenheimer
Lowe's downgraded to Perform from Outperform at Oppenheimer
08/26/20 Jefferies
Lowe's price target raised to $205 from $193 at Jefferies
LOW Lowe's
$159.61 /

-0.52 (-0.32%)

LOW Lowe's
$159.61 /

-0.52 (-0.32%)

LOW Lowe's
$159.61 /

-0.52 (-0.32%)

LOW Lowe's
$159.61 /

-0.52 (-0.32%)

Hot Stocks
GDS Holdings announces accepted offer to acquire Beijing data center » 07:08
09/22/20
09/22
07:08
09/22/20
07:08
GDS

GDS Holdings

$77.13 /

-1.3 (-1.66%)

GDS Holdings announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GDS GDS Holdings
$77.13 /

-1.3 (-1.66%)

GDS GDS Holdings
$77.13 /

-1.3 (-1.66%)

08/25/20 Berenberg
GDS Holdings upgraded to Buy from Hold at Berenberg
08/19/20 Raymond James
GDS Holdings price target raised to $92 from $70 at Raymond James
07/27/20 HSBC
GDS Holdings initiated with a Hold at HSBC
07/20/20
Fly Intel: Top five analyst downgrades
GDS GDS Holdings
$77.13 /

-1.3 (-1.66%)

  • 14
    Jan
  • 06
    Dec
GDS GDS Holdings
$77.13 /

-1.3 (-1.66%)

GDS GDS Holdings
$77.13 /

-1.3 (-1.66%)

Hot Stocks
Commercial Vehicle Group reports progress against FY20 objectives » 07:08
09/22/20
09/22
07:08
09/22/20
07:08
CVGI

Commercial Vehicle Group

$5.24 /

-0.49 (-8.55%)

Commercial Vehicle Group…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CVGI Commercial Vehicle Group
$5.24 /

-0.49 (-8.55%)

CVGI Commercial Vehicle Group
$5.24 /

-0.49 (-8.55%)

08/26/20 Barrington
Commercial Vehicle Group price target raised to $5.50 from $5 at Barrington
08/11/20 Colliers
Commercial Vehicle Group upgraded to Buy following Q2 report at Colliers
08/11/20 Colliers
Commercial Vehicle Group upgraded to Buy from Neutral at Colliers
03/18/20 Barrington
Commercial Vehicle Group price target lowered to $5 from $8.50 at Barrington
CVGI Commercial Vehicle Group
$5.24 /

-0.49 (-8.55%)

Initiation
Aptose Biosciences initiated with a Buy at Alliance Global Partners » 07:08
09/22/20
09/22
07:08
09/22/20
07:08
APTO

Aptose Biosciences

$5.88 /

-0.585 (-9.05%)

Alliance Global Partners…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
APTO Aptose Biosciences
$5.88 /

-0.585 (-9.05%)

APTO Aptose Biosciences
$5.88 /

-0.585 (-9.05%)

09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
08/04/20 Piper Sandler
Piper Sandler likes setup for Aptose Biosciences into ASH meeting
06/12/20 Piper Sandler
Aptose Biosciences' EHA update 'incrementally positive,' says Piper Sandler
06/12/20 JonesTrading
JonesTrading optimistic about potential of Aptose Biosciences' CG-806
APTO Aptose Biosciences
$5.88 /

-0.585 (-9.05%)

  • 16
    Jul
  • 17
    Dec
APTO Aptose Biosciences
$5.88 /

-0.585 (-9.05%)

Earnings
CoreLogic raises FY20 revenue view to $1.92B-$1.95B from $1.86B-$1.9B » 07:07
09/22/20
09/22
07:07
09/22/20
07:07
CLGX

CoreLogic

$67.54 /

+0.23 (+0.34%)

Consensus $1.97B. Raises…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CLGX CoreLogic
$67.54 /

+0.23 (+0.34%)

CLGX CoreLogic
$67.54 /

+0.23 (+0.34%)

07/24/20
Fly Intel: Top five analyst downgrades
07/24/20 Stephens
Stephens sees limited further upside for CoreLogic shares, cuts to Equal Weight
07/24/20 Stephens
CoreLogic downgraded to Equal Weight from Overweight at Stephens
07/24/20 Compass Point
CoreLogic downgraded to Neutral from Buy at Compass Point
CLGX CoreLogic
$67.54 /

+0.23 (+0.34%)

CLGX CoreLogic
$67.54 /

+0.23 (+0.34%)

CLGX CoreLogic
$67.54 /

+0.23 (+0.34%)

Initiation
Syros Pharmaceuticals initiated with a Buy at Alliance Global Partners » 07:07
09/22/20
09/22
07:07
09/22/20
07:07
SYRS

Syros Pharmaceuticals

$10.10 /

+0.11 (+1.10%)

Alliance Global Partners…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SYRS Syros Pharmaceuticals
$10.10 /

+0.11 (+1.10%)

SYRS Syros Pharmaceuticals
$10.10 /

+0.11 (+1.10%)

09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
08/06/20 JMP Securities
Syros Pharmaceuticals price target raised to $20 from $16 at JMP Securities
08/06/20 Piper Sandler
Syros Pharmaceuticals price target raised to $18 from $14 at Piper Sandler
05/29/20 Roth Capital
Syros Pharmaceuticals ASCO update bodes well for ph1 data, says Roth Capital
SYRS Syros Pharmaceuticals
$10.10 /

+0.11 (+1.10%)

Recommendations
Illumina price target lowered to $281 from $335 at Baird » 07:07
09/22/20
09/22
07:07
09/22/20
07:07
ILMN

Illumina

$269.60 /

-25.695 (-8.70%)

Baird analyst Catherine…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ILMN Illumina
$269.60 /

-25.695 (-8.70%)

ILMN Illumina
$269.60 /

-25.695 (-8.70%)

06:17 Today Citi
Illumina acquisition 'adds ambiguity' around valuation, says Citi
06:08 Today UBS
Illumina downgraded to Neutral from Buy at UBS
06:00 Today Stifel
Stifel downgrades Illumina to Hold after 'massively dilutive' deal
05:08 Today Stifel
Illumina downgraded to Hold from Buy at Stifel
ILMN Illumina
$269.60 /

-25.695 (-8.70%)

ILMN Illumina
$269.60 /

-25.695 (-8.70%)

ILMN Illumina
$269.60 /

-25.695 (-8.70%)

ILMN Illumina
$269.60 /

-25.695 (-8.70%)

Hot Stocks
NeuroMetrix launches Quell app for Apple Watch » 07:07
09/22/20
09/22
07:07
09/22/20
07:07
NURO

NeuroMetrix

$1.62 /

-0.1 (-5.81%)

, AAPL

Apple

$110.18 /

+3.52 (+3.30%)

NeuroMetrix (NURO)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NURO NeuroMetrix
$1.62 /

-0.1 (-5.81%)

AAPL Apple
$110.18 /

+3.52 (+3.30%)

NURO NeuroMetrix
$1.62 /

-0.1 (-5.81%)

AAPL Apple
$110.18 /

+3.52 (+3.30%)

09/21/20 Citi
Apple price target raised to $125 from $112.50 at Citi
09/18/20 JPMorgan
Apple Fitness+ contribution will take time, says JPMorgan
09/18/20 Citi
Citi boosts Jabil target to $45 from $40, adds 'Catalyst Watch'
09/17/20 BWS Financial
AXT rumors of Apple win highlight value, says BWS Financial
NURO NeuroMetrix
$1.62 /

-0.1 (-5.81%)

AAPL Apple
$110.18 /

+3.52 (+3.30%)

AAPL Apple
$110.18 /

+3.52 (+3.30%)

AAPL Apple
$110.18 /

+3.52 (+3.30%)

AAPL Apple
$110.18 /

+3.52 (+3.30%)

AAPL Apple
$110.18 /

+3.52 (+3.30%)

Initiation
MEI Pharma initiated with a Buy at Alliance Global Partners » 07:07
09/22/20
09/22
07:07
09/22/20
07:07
MEIP

MEI Pharma

$3.26 /

-0.28 (-7.91%)

Alliance Global Partners…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MEIP MEI Pharma
$3.26 /

-0.28 (-7.91%)

MEIP MEI Pharma
$3.26 /

-0.28 (-7.91%)

07/06/20 SunTrust
MEI Pharma price target lowered to $12 from $16 at SunTrust
05/29/20
Fly Intel: Top five analyst initiations
05/29/20 SunTrust
MEI Pharma initiated with a Buy at SunTrust
04/14/20 JonesTrading
MEI Pharma price target raised to $9 from $6 at JonesTrading
MEIP MEI Pharma
$3.26 /

-0.28 (-7.91%)

  • 17
    Dec
MEIP MEI Pharma
$3.26 /

-0.28 (-7.91%)

MEIP MEI Pharma
$3.26 /

-0.28 (-7.91%)

Initiation
Popular initiated with a Neutral at UBS » 07:06
09/22/20
09/22
07:06
09/22/20
07:06
BPOP

Popular

$36.96 /

-1.12 (-2.94%)

UBS analyst Brock…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BPOP Popular
$36.96 /

-1.12 (-2.94%)

BPOP Popular
$36.96 /

-1.12 (-2.94%)

07/07/20 RBC Capital
Popular price target lowered to $48 from $58 at RBC Capital
03/27/20 BTIG
Popular price target lowered to $54 from $60 at BTIG
03/12/20 BTIG
Popular price target lowered to $60 from $69 at BTIG
BPOP Popular
$36.96 /

-1.12 (-2.94%)

Hot Stocks
Bausch Health, Alfasigma announce resolution of XIFAXAN property litigation » 07:06
09/22/20
09/22
07:06
09/22/20
07:06
BHC

Bausch Health

$16.52 /

-0.695 (-4.04%)

Bausch Health, along with…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BHC Bausch Health
$16.52 /

-0.695 (-4.04%)

BHC Bausch Health
$16.52 /

-0.695 (-4.04%)

09/17/20
Fly Intel: Top five analyst upgrades
09/17/20 BofA
Bausch Health upgraded to Neutral from Underperform at BofA
08/24/20 JPMorgan
Bausch Health shares can double into separation, says JPMorgan
08/24/20 H.C. Wainwright
Bausch Health price target lowered to $50 from $64 at H.C. Wainwright
BHC Bausch Health
$16.52 /

-0.695 (-4.04%)

BHC Bausch Health
$16.52 /

-0.695 (-4.04%)

BHC Bausch Health
$16.52 /

-0.695 (-4.04%)

Hot Stocks
Orthofix, Neo Medical in pact to develop, market single-use spinal solutions » 07:06
09/22/20
09/22
07:06
09/22/20
07:06
OFIX

Orthofix

$29.23 /

-0.63 (-2.11%)

Orthofix Medical…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OFIX Orthofix
$29.23 /

-0.63 (-2.11%)

OFIX Orthofix
$29.23 /

-0.63 (-2.11%)

02/25/20 Cantor Fitzgerald
Orthofix price target lowered to $42 from $48 at Cantor Fitzgerald
10/29/19 Cantor Fitzgerald
Cantor downgrades Orthofix to Neutral, cuts target to $47 from $71
10/29/19 Cantor Fitzgerald
Orthofix downgraded to Neutral from Overweight at Cantor Fitzgerald
OFIX Orthofix
$29.23 /

-0.63 (-2.11%)

Hot Stocks
BlackBerry and Telus announce partnership » 07:05
09/22/20
09/22
07:05
09/22/20
07:05
BB

BlackBerry

$4.77 /

-0.1 (-2.06%)

, TU

Telus

$17.48 /

-0.36 (-2.02%)

BlackBerry (BB) and TELUS…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BB BlackBerry
$4.77 /

-0.1 (-2.06%)

TU Telus
$17.48 /

-0.36 (-2.02%)

BB BlackBerry
$4.77 /

-0.1 (-2.06%)

06/25/20 Scotiabank
BlackBerry price target raised to $5 from $4.50 at Scotiabank
06/25/20 Canaccord
BlackBerry improvement anticipated throughout year, says Canaccord
04/01/20 MKM Partners
BlackBerry price target lowered to $4.50 from $7.00 at MKM Partners
04/01/20 TD Securities
BlackBerry downgraded to Hold from Buy at TD Securities
TU Telus
$17.48 /

-0.36 (-2.02%)

08/04/20 RBC Capital
Telus price target raised to C$25 from C$24 at RBC Capital
08/04/20 Scotiabank
Telus price target raised to C$27.50 from C$27 at Scotiabank
06/03/20 Canaccord
Telus price target raised to C$24 from C$23 at Canaccord
05/08/20 CIBC
Telus price target lowered to C$26 from C$27 at CIBC
BB BlackBerry
$4.77 /

-0.1 (-2.06%)

BB BlackBerry
$4.77 /

-0.1 (-2.06%)

BB BlackBerry
$4.77 /

-0.1 (-2.06%)

BB BlackBerry
$4.77 /

-0.1 (-2.06%)

TU Telus
$17.48 /

-0.36 (-2.02%)

Earnings
CoreLogic raises Q3 revenue view to $525M-$535M from $485M-$515M » 07:05
09/22/20
09/22
07:05
09/22/20
07:05
CLGX

CoreLogic

$67.54 /

+0.23 (+0.34%)

Consensus $495.81M.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CLGX CoreLogic
$67.54 /

+0.23 (+0.34%)

CLGX CoreLogic
$67.54 /

+0.23 (+0.34%)

07/24/20
Fly Intel: Top five analyst downgrades
07/24/20 Stephens
Stephens sees limited further upside for CoreLogic shares, cuts to Equal Weight
07/24/20 Stephens
CoreLogic downgraded to Equal Weight from Overweight at Stephens
07/24/20 Compass Point
CoreLogic downgraded to Neutral from Buy at Compass Point
CLGX CoreLogic
$67.54 /

+0.23 (+0.34%)

CLGX CoreLogic
$67.54 /

+0.23 (+0.34%)

CLGX CoreLogic
$67.54 /

+0.23 (+0.34%)

General news
European stock markets are broadly higher » 07:05
09/22/20
09/22
07:05
09/22/20
07:05

European stock markets…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Initiation
Immutep initiated with a Buy at Alliance Global Partners » 07:04
09/22/20
09/22
07:04
09/22/20
07:04
IMMP

Immutep

$1.83 /

-0.055 (-2.92%)

Alliance Global Partners…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IMMP Immutep
$1.83 /

-0.055 (-2.92%)

IMMP Immutep
$1.83 /

-0.055 (-2.92%)

06/02/20 JonesTrading
Immutep ASCO presentations point to expanding utility of efti, says JonesTrading
Hot Stocks
Renalytix AI receives California commercial laboratory certification » 07:04
09/22/20
09/22
07:04
09/22/20
07:04
RNLX

Renalytix AI

$12.33 /

-0.92 (-6.94%)

Renalytix AI announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RNLX Renalytix AI
$12.33 /

-0.92 (-6.94%)

RNLX Renalytix AI
$12.33 /

-0.92 (-6.94%)

08/11/20 JPMorgan
Renalytix AI initiated with a Neutral at JPMorgan
08/11/20 Stifel
Renalytix AI initiated with a Buy at Stifel
  • 17
    Jul
RNLX Renalytix AI
$12.33 /

-0.92 (-6.94%)

Hot Stocks
Bristol-Myers, bluebird bio get FDA priority review for Ide-cel » 07:03
09/22/20
09/22
07:03
09/22/20
07:03
BMY

Bristol-Myers

$57.77 /

-1.49 (-2.51%)

, BLUE

Bluebird Bio

$54.41 /

-2.2 (-3.89%)

Bristol Myers Squibb…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BMY Bristol-Myers
$57.77 /

-1.49 (-2.51%)

BLUE Bluebird Bio
$54.41 /

-2.2 (-3.89%)

BMY Bristol-Myers
$57.77 /

-1.49 (-2.51%)

08/25/20 Piper Sandler
Bristol's trial miss has 'no financial impact' on Agios, says Piper Sandler
08/06/20 Citi
Investors can refocus on Bristol-Myers story after Eliquis win, says Citi
07/28/20 Mizuho
Wait for Bristol-Myers' bb2121 submission making some 'nervous,' says Mizuho
07/28/20
Fly Intel: Top five analyst initiations
BLUE Bluebird Bio
$54.41 /

-2.2 (-3.89%)

08/06/20 Wedbush
Bluebird Bio price target lowered to $81 from $89 at Wedbush
06/12/20 Piper Sandler
Bluebird Bio update 'modestly positive,' says Piper Sandler
06/10/20 Stifel
Stifel says Bluebird setup 'downside biased,' Crispr's 'upside biased' into EHA
05/13/20 Stifel
Bluebird's ide-cel remains approvable despite FDA's 'strict stance,' says Stifel
BMY Bristol-Myers
$57.77 /

-1.49 (-2.51%)

BLUE Bluebird Bio
$54.41 /

-2.2 (-3.89%)

  • 19
    May
BMY Bristol-Myers
$57.77 /

-1.49 (-2.51%)

BMY Bristol-Myers
$57.77 /

-1.49 (-2.51%)

BLUE Bluebird Bio
$54.41 /

-2.2 (-3.89%)

BMY Bristol-Myers
$57.77 /

-1.49 (-2.51%)

Hot Stocks
Blueprint Medicines announces results from trials of AYVAKIT » 07:03
09/22/20
09/22
07:03
09/22/20
07:03
BPMC

Blueprint Medicines

$77.24 /

-2.14 (-2.70%)

Blueprint Medicines…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BPMC Blueprint Medicines
$77.24 /

-2.14 (-2.70%)

BPMC Blueprint Medicines
$77.24 /

-2.14 (-2.70%)

09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
09/07/20 Piper Sandler
Early approval of Blueprint's Gavreto 'a nice surprise,' says Piper Sandler
07/15/20 Deutsche Bank
Blueprint Medicines price target raised to $95 from $85 at Deutsche Bank
07/15/20 H.C. Wainwright
Blueprint Medicines price target raised to $110 from $66 at H.C. Wainwright
BPMC Blueprint Medicines
$77.24 /

-2.14 (-2.70%)

  • 23
    Jan
BPMC Blueprint Medicines
$77.24 /

-2.14 (-2.70%)

Initiation
Almaden Minerals initiated with a Buy at Alliance Global Partners » 07:03
09/22/20
09/22
07:03
09/22/20
07:03
AAU

Almaden Minerals

$0.89 /

-0.0562 (-5.92%)

Alliance Global Partners…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AAU Almaden Minerals
$0.89 /

-0.0562 (-5.92%)

Hot Stocks
ALX Oncology, Merck to collaborate on Phase 2 immuno-oncology studies of ALX148 » 07:03
09/22/20
09/22
07:03
09/22/20
07:03
ALXO

ALX Oncology

$36.33 /

-1.11 (-2.96%)

, MRK

Merck

$83.11 /

-2.71 (-3.16%)

ALX Oncology (ALXO)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ALXO ALX Oncology
$36.33 /

-1.11 (-2.96%)

MRK Merck
$83.11 /

-2.71 (-3.16%)

ALXO ALX Oncology
$36.33 /

-1.11 (-2.96%)

09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
08/27/20 Piper Sandler
ALX Oncology on track for catalyst-rich 12 months, says Piper Sandler
08/11/20 Cantor Fitzgerald
ALX Oncology initiated with an Overweight at Cantor Fitzgerald
08/11/20 Cantor Fitzgerald
ALX Oncology initiated with an Overweight at Cantor Fitzgerald
MRK Merck
$83.11 /

-2.71 (-3.16%)

09/21/20 Piper Sandler
Regeneron's Libtayo delivered results on par with Keytruda, says Piper Sandler
09/15/20 SVB Leerink
Seattle Genetics price target raised to $185 from $173 at SVB Leerink
09/14/20 RBC Capital
Seattle Genetics price target raised to $191 from $175 at RBC Capital
09/14/20 Piper Sandler
Seattle Genetics price target raised to $172 from $165 at Piper Sandler
ALXO ALX Oncology
$36.33 /

-1.11 (-2.96%)

MRK Merck
$83.11 /

-2.71 (-3.16%)

  • 17
    Jul
MRK Merck
$83.11 /

-2.71 (-3.16%)

ALXO ALX Oncology
$36.33 /

-1.11 (-2.96%)

MRK Merck
$83.11 /

-2.71 (-3.16%)

MRK Merck
$83.11 /

-2.71 (-3.16%)

Initiation
Adyen initiated with a Hold at Loop Capital » 07:01
09/22/20
09/22
07:01
09/22/20
07:01
ADYEY

Adyen

$0.00 /

+ (+0.00%)

Loop Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ADYEY Adyen
$0.00 /

+ (+0.00%)

09/04/20 HSBC
Adyen initiated with a Buy at HSBC
08/26/20 Morgan Stanley
Adyen sees 'ample opportunity' to grow with merchants, says Morgan Stanley
08/24/20 JPMorgan
Adyen's 2020 processed volume estimate cut at JPMorgan
08/21/20 Barclays
Adyen price target raised to EUR 940 from EUR 920 at Barclays
Initiation
Flower One resumed with a Speculative Buy at Canaccord » 07:01
09/22/20
09/22
07:01
09/22/20
07:01
FLOOF

Flower One

$0.00 /

+ (+0.00%)

Canaccord Genuity analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FLOOF Flower One
$0.00 /

+ (+0.00%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.